Vice President, Global Program Lead Neuroscience

Defines and executes the strategic integrated development plan (IDP) in partnership with the cross functional GPT members

Participates in regulatory filings (NDA, BLA filings) as well as develops strategy for orphan drug designation

Engages with Health Authorities and/or Advisory Committees

Leads team to develop program strategy and clinical program, commercialization strategy plans, business case development, and understands how access, pricing and reimbursement needs for supporting value proposition will inform trial design

Builds and maintains collaborative relationships with external stakeholders (Opinion Leaders, Strategic Alliance Partners, Patient Advocacy Leaders, Health Authorities) and appropriately incorporates insights and advice to maximize program impact

Actively supports Investor Relations and Public Affairs in managing external BMS communications

Understands necessary commercial inputs needed to inform the end-to-end development process leading to regulatory approval and successful commercialization 

Integrates market inputs (e.g., TPP, DEX/VAP, CI insights) into the integrated development plan, incl., clinical plans and labeling strategy; Appreciates translation of clinical data into claims and considerations for label development

Understands and contributes to development of forecasts and investment scenarios, how to assess risk and conduct valuations, and implications for decision making

Contributes to the development of brand hallmarks and brand strategy (generic name, brand name, logo, brand colors, positioning, messaging, campaign, segmentation, promotional strategy) understanding the relationship to clinical trial design

In partnership with Medical Affairs, supports development of KOL plans and engagements, and leverages KOL input in context of development programs and communicating evidence

Supports commercial needs and recommendations to guide CMC and GPS on trade packaging and commercial product

Utilizes various resources to design clinical trials that are competitively differentiating (e.g., competitive intelligence knowledge, KOL input)

Actively participates with Health Authorities in finalizing clinical design and adequate endpoints

Understands clinical trial operational complexities from study start up through enrollment, quality assurance, and study readout

Has an active role in analysis and/or interpretation of clinical data and translation into scientific communication strategy, including publications, and commercial strategy

Understands and reflects the impact of VAP inputs (Early Access Review and DEX recommendations, commercial opportunity assessment, TOP/TPP requirements, and value drivers as inputs in clinical trial design

Inclusively Collaborates Across the BMS Matrix with an Enterprise Mindset: Effectively collaborates with matrix functions by building trust and driving toward the collective success of the program

Demonstrates Enterprise Mindset Problem-Solving and Decision Making: Gathers diverse perspectives assess alternate resolutions and makes thoughtful, informed Enterprise decisions

Develops and Leads a High Performing Matrix Team: Builds, leads and inspires high performing cross functional matrix team through a unified program strategy on behalf of our patients

Holds Oneself and Others Accountable: Takes initiative to address challenges, removes barriers, holds others accountable for the collective success of the program outcomes and team collaboration

Demonstrates Character: Leads with the values, self-awareness, and humility, seeks feedback, Includes integrity

BS/BA required, and an advanced degree preferred (MD, PhD, MBA, PharmD, etc.) must have experience in the drug development process

Proven demonstrated leadership capability; previous experience in building and leading a high performing team

A minimum of 10 years in the drug development & commercialization process, Health Authorities and/or academic experience, and clinical trial design with proven progression in relevant roles

Significant experience in related therapeutic area

Extensive working knowledge in the end-to-end drug development process, along with expertise in one or more of the relevant areas (e.g., clinical, regulatory, project planning and management, medical, commercial development)

Prior experience in building a development plan that was aligned with a broader strategy (TA/Franchise) and endorsed by governance

Experience in building trusting cross-functional stakeholder partnerships in a matrix organization

Demonstrated ability to constructively influence peers and senior leaders across the enterprise

Working knowledge of regulations in the pharmaceutical industry (US and Global preferred)

Demonstrated ability to effectively collaborate across geographic and functional boundaries (e.g. early development, R&D, disease strategy teams, marketing, access, etc.) and building strong external relationships

Ability to navigate through a complex and dynamic healthcare environment

Track record of successfully executing on large, complex projects, with a preference for successful drug trial oversight and execution

Abreast of scientific issues as they impact business development and strategic planning

Success in situations requiring rigorous, analytical problem solving and the ability to determine scientific opportunity and commercial targets

Broad understanding of domestic and international issues relative to the pharmaceutical industry

Proven agility in prioritizing and navigating competing demands

For late development projects, prior submission experience is highly preferred